Infinity Pharmaceuticals | INFI - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
AbbVie USD 4.55B 757M 2025-12
Amgen USD 1.79B 128M 2025-12
AstraZeneca USD 3.27B 471M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Cipla INR 29.1B 1.16B 2025-12
Clal Biotechnology ILS 16.49M 2.64M 2022-06
Compugen USD 1.65M 10K 2025-09
CSL USD 3.87B 2.08B 2025-12
Eisai JPY 51.08B 5.56B 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
Grifols EUR 1.32B 22.75M 2025-09
Incyte USD 121.18M 22.18M 2025-12
Infinity Pharmaceuticals USD 352K 89K 2023-06
Ionis Pharmaceuticals USD 8M 5.66M 2025-12
J&J USD 7.97B 689M 2025-12
Novartis USD 3.54B 217M 2025-09
Pfizer USD 6.29B 2.12B 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
TG Therapeutics USD 38.14M 10.05M 2025-12